WAVE Life Sciences Ltd.
WVE
$13.02
-$0.33-2.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -204.38M | -121.95M | -129.87M | -112.33M | -97.01M |
| Total Depreciation and Amortization | 8.85M | 8.75M | 8.67M | 8.65M | 8.66M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.97M | 20.87M | 17.92M | 15.21M | 13.14M |
| Change in Net Operating Assets | -16.94M | -105.03M | -95.90M | -92.17M | -75.82M |
| Cash from Operations | -187.49M | -197.37M | -199.18M | -180.63M | -151.03M |
| Capital Expenditure | -718.00K | -805.00K | -940.00K | -686.00K | -938.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -718.00K | -805.00K | -940.00K | -686.00K | -938.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 441.30M | 83.55M | 240.50M | 229.46M | 239.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.94M | -24.00K | 14.08M | 14.08M | 14.08M |
| Cash from Financing | 488.24M | 83.52M | 254.58M | 243.54M | 253.89M |
| Foreign Exchange rate Adjustments | 12.00K | -31.00K | 118.00K | -6.00K | -138.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 300.04M | -114.68M | 54.58M | 62.21M | 101.79M |